Expertise in
2
conditions

Philippe Merle

Umr Inserm U1052 Cnrs5286, Crcl, 151, 
Lyon, FR 
Expertise in
2
conditions
Umr Inserm U1052 Cnrs5286, Crcl, 151, 
Lyon, FR 

Overview

Philippe Merle practices practicing medicine in Lyon, France.

Mr. Merle is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Hepatitis, Hepatitis B, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

He is actively involved in clinical research, co-authoring 138 peer reviewed articles and participating in 10 clinical trials.

Gender

Male

Locations

Umr Inserm U1052 Cnrs5286, Crcl, 151, Lyon, 69008, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Diagnostic test
Muscle Oxygenation Modification During Effort in 4 Groups of Neuromuscular Diseases Compared to Healthy Controls, and Mitochondrial Function and Phenotype Assessment
Muscle Oxygenation Modification During Effort in 4 Groups of Neuromuscular Diseases Compared to Healthy Controls, and Mitochondrial Function and Phenotype Assessment
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Other
Study Phase: Not Applicable
CLERANCE HCC, Cabozantinib toLERANCE Study in HepatoCellular Carcinoma
CLERANCE HCC, Cabozantinib toLERANCE Study in HepatoCellular Carcinoma
Enrollment Status: Completed
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 4
Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II
Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II
Enrollment Status: Completed
Publish Date: July 04, 2025
Intervention Type: Drug, Device
Study Phase: Phase 2
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Enrollment Status: Completed
Publish Date: May 03, 2024
Intervention Type: Drug
Study Phase: Phase 1
Potential Interest of Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) for the Selection of Patients Proposed for Curative Treatment of a Hepatocellular Carcinoma
Potential Interest of Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) for the Selection of Patients Proposed for Curative Treatment of a Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: October 31, 2023
Intervention Type: Device
Study Phase: Not Applicable
Phase 1/2a Study to Evaluate the Safety, Activity, and Pharmacokinetics of Escalating Doses of GNS561 in Patients With Primary and Secondary Liver Cancer
Phase 1/2a Study to Evaluate the Safety, Activity, and Pharmacokinetics of Escalating Doses of GNS561 in Patients With Primary and Secondary Liver Cancer
Enrollment Status: Terminated
Publish Date: May 02, 2022
Intervention Type: Drug
Study Drug: GNS561
Study Phase: Phase 1/Phase 2
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: December 27, 2021
Intervention Type: Other
Study Phase: Phase 2
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Doxorubicin Transdrug™ to Best Standard of Care in Patients With Advanced Hepatocellular Carcinoma. ReLive Study.
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Doxorubicin Transdrug™ to Best Standard of Care in Patients With Advanced Hepatocellular Carcinoma. ReLive Study.
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

138 Total Publications

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026

Frequently Asked Questions about Philippe Merle

Is Philippe Merle a top-rated expert for Liver Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Philippe Merle is classified as an Elite expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Philippe Merle participate in research or clinical trials?

Yes. Philippe Merle has published 138 articles and abstracts on conditions like Liver Cancer. You can view a list of Philippe Merle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Merle's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile